Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Hartmann

Showing results (331-340 of 626) with videos related to

Pageof 63
Sort By:
Journal of Medicinal Chemistry|February 16, 1996
Tetrahydronaphthalenes: influence of heterocyclic substituents on inhibition of steroid enzymes P450 arom and P450 17G A Wächter, R W Hartmann, T Sergejew, et al.
Journal of Medicinal Chemistry|July 14, 2012
Novel imidazol-1-ylmethyl substituted 1,2,5,6-tetrahydropyrrolo[3,2,1-ij]quinolin-4-ones as potent and selective CYP11B1 inhibitors for the treatment of Cushing's syndromeLina Yin, Simon Lucas, Frauke Maurer, et al.
Blut|April 1, 1981
High-dose nitrogen mustard (HN2) with autologous nonfrozen bone marrow transplantation in advanced malignant melanoma. A phase I trialD W Hartmann, W A Robinson, N J Morton, et al.
Archiv Der Pharmazie|July 9, 2004
Synthesis and evaluation of a dimer of 2-(4-pyridylmethyl)-1-indanone as a novel nonsteroidal aromatase inhibitorRanju Gupta, Dharam Paul Jindal, Birinder Jit, et al.
Experimental Cell Research|December 10, 1999
IGF-II enhances trichostatin A-induced TGFbeta1 and p21(Waf1,Cip1, sdi1) expression in Hep3B cellsS G Gray, T Yakovleva, W Hartmann, et al.
Journal of Medicinal Chemistry|December 4, 2008
In vivo active aldosterone synthase inhibitors with improved selectivity: lead optimization providing a series of pyridine substituted 3,4-dihydro-1H-quinolin-2-one derivativesSimon Lucas, Ralf Heim, Christina Ries, et al.
Disease Management : DM|October 28, 2003
Care management for persistent pain: an introductionChristine W Hartmann, Neil I Goldfarb, Susan S Kim, et al.
Archiv Der Pharmazie|July 12, 2008
Structural modifications of salicylates: inhibitors of human CD81-receptor HCV-E2 interactionMarcel Holzer, Sigrid Ziegler, Alexander Neugebauer, et al.
European Journal of Medicinal Chemistry|November 1, 2011
Triazole ring-opening leads to the discovery of potent nonsteroidal 17β-hydroxysteroid dehydrogenase type 2 inhibitorsKuiying Xu, Yaseen A Al-Soud, Marie Wetzel, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|July 10, 1999
Unexpected pregnancy during hormone-replacement therapy in a woman with elevated follicle-stimulating hormone levels and amenorrheaT Laml, J C Huber, A E Albrecht, et al.
Pageof 63

Showing results (331-340 of 626) with videos related to

Sort By:
Pageof 63
Journal of Medicinal Chemistry|February 16, 1996
Tetrahydronaphthalenes: influence of heterocyclic substituents on inhibition of steroid enzymes P450 arom and P450 17G A Wächter, R W Hartmann, T Sergejew, et al.
Journal of Medicinal Chemistry|July 14, 2012
Novel imidazol-1-ylmethyl substituted 1,2,5,6-tetrahydropyrrolo[3,2,1-ij]quinolin-4-ones as potent and selective CYP11B1 inhibitors for the treatment of Cushing's syndromeLina Yin, Simon Lucas, Frauke Maurer, et al.
Blut|April 1, 1981
High-dose nitrogen mustard (HN2) with autologous nonfrozen bone marrow transplantation in advanced malignant melanoma. A phase I trialD W Hartmann, W A Robinson, N J Morton, et al.
Archiv Der Pharmazie|July 9, 2004
Synthesis and evaluation of a dimer of 2-(4-pyridylmethyl)-1-indanone as a novel nonsteroidal aromatase inhibitorRanju Gupta, Dharam Paul Jindal, Birinder Jit, et al.
Experimental Cell Research|December 10, 1999
IGF-II enhances trichostatin A-induced TGFbeta1 and p21(Waf1,Cip1, sdi1) expression in Hep3B cellsS G Gray, T Yakovleva, W Hartmann, et al.
Journal of Medicinal Chemistry|December 4, 2008
In vivo active aldosterone synthase inhibitors with improved selectivity: lead optimization providing a series of pyridine substituted 3,4-dihydro-1H-quinolin-2-one derivativesSimon Lucas, Ralf Heim, Christina Ries, et al.
Disease Management : DM|October 28, 2003
Care management for persistent pain: an introductionChristine W Hartmann, Neil I Goldfarb, Susan S Kim, et al.
Archiv Der Pharmazie|July 12, 2008
Structural modifications of salicylates: inhibitors of human CD81-receptor HCV-E2 interactionMarcel Holzer, Sigrid Ziegler, Alexander Neugebauer, et al.
European Journal of Medicinal Chemistry|November 1, 2011
Triazole ring-opening leads to the discovery of potent nonsteroidal 17β-hydroxysteroid dehydrogenase type 2 inhibitorsKuiying Xu, Yaseen A Al-Soud, Marie Wetzel, et al.
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|July 10, 1999
Unexpected pregnancy during hormone-replacement therapy in a woman with elevated follicle-stimulating hormone levels and amenorrheaT Laml, J C Huber, A E Albrecht, et al.
Pageof 63